Cromos Pharma, where the patients are

Patheon

DPx launched by JLL Partners, Royal DSM

Wednesday, March 12, 2014 01:43 PM

JLL Partners and Royal DSM have launched DPx Holdings, a global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries.

More... »

CRF Health eCOA webinar series

Royal DSM, JLL create jointly owned CDMO

Wednesday, November 20, 2013 12:48 PM

JLL Partners, a middle-market private equity firm, and Royal DSM, a global life sciences and materials sciences company, have created a new global contract development and manufacturing organization (CDMO) for the pharmaceutical industry, with anticipated sales of around $2 billion. It will be 51% owned by JLL and 49% owned by DSM.

More... »


Aesica appoints two business development managers

Monday, July 15, 2013 01:32 PM

Aesica, a global contract development and manufacturing organization (CDMO), has appointed Sven Thomas and David Ross business development managers. They will ensure potential customers are aware of how their manufacturing and development needs can be supported.

More... »

Patheon increases investment in Milton Park, U.K. facility

Monday, February 4, 2013 12:27 PM

Patheon, a provider of contract development and commercial manufacturing services, has announced plans for additional investment in its Milton Park facility. Located in Oxfordshire, U.K., Milton Park is a dedicated pharmaceutical development services facility focused on early development projects.

More... »

Patheon to acquire Banner Pharmacaps

Tuesday, October 30, 2012 10:24 AM

Patheon, a Durham, N.C.-based provider of contract development and manufacturing services, has signed a definitive agreement with Vion, a global manufacturer of foodstuffs and ingredients based in the Netherlands, to acquire Banner Pharmacaps, a High Point, N.C.-based specialty pharmaceutical business dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

More... »

Hovione appoints Minchom vice president

Wednesday, March 14, 2012 09:14 AM

Dr. Colin Minchom has been appointed as vice president of Hovione’s particle design business unit. He will be based in East Windsor, N.J., and report to Guy Villax, CEO of Hovione.

More... »

Patheon promotes Mancuso

Tuesday, January 31, 2012 08:30 AM

Patheon, a global provider of drug development and manufacturing services, has promoted Antonella Mancuso to president, global commercial operations and chief manufacturing officer, responsible for Patheon's global commercial  manufacturing operations. Mancuso will assume responsibility for all of Patheon's commercial operating units in North America and Europe. 

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs